Meeting Overview - The second extraordinary general meeting of shareholders for Zhongyuan Neipei Group Co., Ltd. is scheduled for December 8, 2025, at 14:30 [1] - The meeting will be held both in-person and via online voting, with specific time slots for each voting method [1] - The record date for shareholders to participate is December 1, 2025 [1] Attendance - A total of 295 shareholders attended the meeting, representing 140,726,529 shares, which is 23.9164% of the total voting shares [1] - Among them, 11 shareholders attended in person, representing 136,790,618 shares (23.2475%), while 284 participated online, representing 3,935,911 shares (0.6689%) [2] - 289 small shareholders participated, representing 34,952,351 shares (5.9401%) [2] Proposals and Voting Results - The following proposals were approved during the meeting: 1. **External Investment Management System**: Approved by 139,575,629 shares (99.1822%) [4] 2. **Securities Investment Management System**: Approved by 139,485,129 shares (99.1179%) [5] 3. **External Guarantee Management Measures**: Approved by 139,455,129 shares (99.0965%) [6] 4. **Related Party Transaction Decision-Making System**: Approved by 139,586,529 shares (99.1899%) [7] 5. **External Financial Assistance Management System**: Approved by 139,451,829 shares (99.0942%) [8] 6. **Profit Distribution Management System**: Approved by 139,444,429 shares (99.0889%) [10] 7. **Appointment of Accounting Firm System**: Approved by 140,007,329 shares (99.4889%) [11] 8. **Cumulative Voting System Implementation Rules**: Approved by 140,005,029 shares (99.4873%) [12] 9. **Management System for Directors and Senior Management Compensation**: Approved by 140,001,529 shares (99.4848%) [13] Legal Opinion - The meeting was witnessed by lawyers from Beijing Dacheng Law Firm, confirming that the meeting's procedures complied with relevant laws and regulations [14]

北 京 大 成律 师 事务 所 关 于 2025 年 第 二 次临 时 股 东 会 中 原内 配 集 团 股 份 有限 公 司 之 法 律意 见 书 北 京 大 成 律 师 事 务 所 www.dentons.cn 北京市朝阳区朝阳门南大街 10 号兆泰国际中心 B 座 16-21 层 16-21F, Tower B, ZT INTERNATIONAL CENTER, No.10, Chaoyangmen Nandajie, Chaoyang District, Beijing Tel: +86 10-58137799 Fax: +86 10-58137788 北京大成律师事务所 关于中原内配集团股份有限公司 2025 年第二次临时股东会之法律意见书 致：中原内配集团股份有限公司 根据《中华人民共和国证券法》（以下简称"《证券法》"）、《中华人民共 和国公司法》（以下简称"《公司法》"）和中国证券监督管理委员会《上市公司 股东会规则》（以下简称"《股东会规则》"）等法律、法规和其他有关规范性文 件的要求，北京大成律师事务所（以下简称"本所"）接受中原内配集团股份有限 公司（以下简称"公司"）的委托，指派律师参 ...

本公司及董事会全体成员保证公告内容真实、准确、完整，没有虚假记载、 误导性陈述或者重大遗漏。 重要提示： 1、本次股东会未出现否决提案的情形。 2、本次股东会不涉及变更以往股东会已通过的决议的情形。 证券代码：002448 证券简称：中原内配 公告编号：2025-045 中原内配集团股份有限公司 2025年第二次临时股东会决议公告 一、 召开会议基本情况 （一）会议召开时间 （二）会议召开地点：公司二楼会议室 （三）会议召集人：公司董事会 1、现场会议时间：2025年12月8日（周一）下午14：30 （四）现场会议主持人：董事长薛亚辉先生 2、网络投票时间 通过深圳证券交易所交易系统进行网络投票的时间为：2025年12月8日上午 9:15-9:25、9:30-11:30，下午13:00-15:00； 通过深圳证券交易所互联网投票系统投票的时间为2025年12月8日9：15至 2025年12月8日15：00期间的任意时间。 （五）召开方式：现场投票与网络投票相结合的方式 （六）股权登记日：2025年12月1日（周一） 其中：通过现场投票的中小股东 5 人，代表股份 31,016,440 股，占公司有表 决权股份 ...

分组1 - Weili Medical plans to distribute a cash dividend of 2 yuan per 10 shares to all shareholders, based on an undistributed profit of 704 million yuan as of September 30, 2025 [1] - Tongding Interconnect's shareholder plans to reduce their stake by up to 0.49%, equating to a maximum of 605,800 shares [1] - Caitong Securities has received approval from the China Securities Regulatory Commission to issue short-term corporate bonds with a total face value of up to 5 billion yuan [1] 分组2 - Youfu Food intends to use 70 million yuan of its own funds to invest in wealth management products with expected annual returns of up to 4.2% [3] - Keres received an administrative regulatory decision from the Guangdong Securities Regulatory Bureau for violations related to accounts receivable aging calculations and related party transactions [5] - Ouma Software's controlling shareholder has completed the transfer of state-owned equity, changing the controlling shareholder to Shandong Guotou [7] 分组3 - ST Huapeng's wholly-owned subsidiary has completed a major overhaul project and is now in production [8] - Beiqi Blue Valley has received approval from the China Securities Regulatory Commission for a stock issuance to specific investors [8] - Weijie Chuangxin received a government subsidy of 5 million yuan, accounting for 21.07% of its projected net profit for 2024 [9] 分组4 - China Resources Double Crane's subsidiary has received a drug registration certificate for a hypertension treatment drug [11] - Huafeng shares are continuing to suspend trading due to a planned change in control [13] - Kaifa Electric's shareholder plans to transfer 36.6869 million shares, representing 11.63% of the total share capital [14] 分组5 - Heng Rui Medicine has received approval for two clinical trials for innovative anti-tumor drugs [15] - Kosen Technology plans to invest 30 million USD to establish a new production base in Malaysia [17] - Sanxing Medical's subsidiary is expected to win a procurement project from the State Grid worth approximately 107 million yuan [18] 分组6 - Sitai Li's subsidiary has received a drug registration certificate for a contrast agent used in MRI [21] - Daren Tang's subsidiary has received a drug registration certificate for a pain relief gel [22] - Saike Xide has received approval for three medical device products, expanding its product range in the in vitro diagnostic field [23] 分组7 - Hasa Lian has elected a new chairman and vice chairman for its board of directors [24] - Two-sided Needle's subsidiary plans to invest 68.8522 million yuan in a production base expansion project [25] - Sunshine Nuohe plans to transfer 70% of its controlling subsidiary's equity for 2 million yuan [26] 分组8 - Hengbang shares received an administrative regulatory decision from the Shandong Securities Regulatory Bureau for failing to complete the election of independent directors [27] - Huali shares plan to sign a related transaction contract worth approximately 59.2847 million yuan [28] - Shangwei shares plan to invest 520.4 million yuan to gain a controlling stake in Sichuan Zhongfu Taihua [30] 分组9 - Zejing Pharmaceutical's ZG006 has been included in the list of breakthrough therapeutic varieties for treating advanced neuroendocrine cancer [32] - Yaopi Glass's shareholder plans to reduce their stake by up to 2.26%, equating to a maximum of 21.1469 million shares [34] - Huate Gas has initiated a major lawsuit involving a claim of 180 million yuan [36] 分组10 - Zhongchumei's controlling shareholder plans to increase their stake by between 42 million and 80 million yuan [37] - Huitong shares' shareholder plans to reduce their stake by up to 1% [38] - Miaowei Exhibition plans to apply for an initial public offering of H shares on the Hong Kong Stock Exchange [40] 分组11 - Tianqi Lithium's subsidiary has appealed to the Chilean Supreme Court regarding a partnership agreement with SQM and Codelco [42] - Naxin Micro plans to repurchase shares worth between 200 million and 400 million yuan [44] - Pingao shares have reported significant uncertainty regarding future business development and profitability [46] 分组12 - Shunyu shares have been pre-selected for a project worth 1.023 billion yuan [48] - Zhongyuan Neipei plans to acquire a 2.5% share in an aerospace industry fund for 50 million yuan [50] - Huifa Food's shareholder plans to reduce their stake by up to 3%, equating to a maximum of 727.14 million shares [53] 分组13 - Junshi Biosciences' subcutaneous PD-1 new formulation has reached its primary endpoint in a Phase III clinical trial [54] - Industrial Fulian clarified that it has not lowered its fourth-quarter profit target amid market rumors [55] - Longpan Technology's subsidiary has signed a major supply agreement for lithium iron phosphate materials, significantly increasing the supply volume [56]

Group 1 - The company Zhongyuan Neipei plans to acquire a partnership share in the Henan Aerospace Industry Fund for a nominal price of 0 RMB, contributing 50 million RMB to enhance resource integration and optimize asset allocation [2] - The Henan Aerospace Industry Fund has a total subscribed capital of 2 billion RMB, focusing on investments in rockets, satellite materials, components, and high-quality projects in the aerospace industry chain [2] - Zhongyuan Neipei was established in December 1996, with a registered capital of approximately 588.41 million RMB, and specializes in the research, production, and sales of core automotive components [2] Group 2 - The company's revenue for the years 2022, 2023, 2024, and the first three quarters of 2025 were 2.302 billion RMB, 2.864 billion RMB, 3.310 billion RMB, and 2.867 billion RMB, reflecting year-on-year growth rates of -6.01%, 24.45%, 15.57%, and 16.35% respectively [3] - The net profit attributable to the parent company for the same periods were 167 million RMB, 311 million RMB, 204 million RMB, and 326 million RMB, with year-on-year growth rates of -20.82%, 85.75%, -34.37%, and 39.89% respectively [3] - The company's asset-liability ratios for the years 2022, 2023, 2024, and the first three quarters of 2025 were 35.06%, 34.32%, 32.69%, and 31.59% respectively [3]

Investment Overview - Company plans to acquire a partnership interest in the Henan Aerospace Industry Fund for a nominal price of 0 yuan, corresponding to a subscribed capital of 50 million yuan [1] - The transaction does not constitute a related party transaction or a major asset restructuring as defined by relevant regulations, and does not require approval from regulatory authorities [1][2] - The investment decision falls within the authority of the chairman and does not require board or shareholder approval [1] Henan Aerospace Industry Fund Overview - The Henan Aerospace Industry Fund was established on September 6, 2025, with a total subscribed capital of 2 billion yuan [2][3] - The fund is managed by Shenzhen Guoyu Gao Hua Investment Management Co., Ltd., and is registered as a private equity fund [4][9] - As of now, the fund has received 281 million yuan in actual contributions from its partners [3] Transaction Details - The transferor of the partnership interest is Jiaozuo Tongcai Innovation and Entrepreneurship Investment Fund, which will transfer a total of 50 million yuan in unpaid capital to the company [5][29] - The transfer does not involve any related party relationships or interests between the company and the transferor [5][6] - The transaction includes a total of 10 million yuan in unpaid capital being transferred to the company, with the remaining amounts allocated to other parties [30][31] Partnership Agreement Highlights - The partnership agreement aims to create satisfactory investment returns through equity investments in target companies [37] - The fund has a total subscribed capital of 2 billion yuan, with an investment period of seven years and a possible extension of up to two years [38][39] - The fund will primarily invest in the aerospace industry, focusing on rockets, satellite materials, and components [42] Financial and Operational Impact - The investment is intended to enhance the company's resource integration capabilities and optimize asset allocation without impacting its main business operations [49] - The funding for this investment will come from the company's own or raised funds, ensuring no adverse effects on the company's financial status [49] - The company will not have control over the Henan Aerospace Industry Fund, as it will only hold a limited partnership interest [50]

人民财讯11月24日电，中原内配(002448)11月24日公告，公司拟以0元价格受让焦作通财持有的河南空 天产业基金对应认缴出资5000万元(实缴出资额0元)的合伙份额，并作为有限合伙人与河南空天产业基 金其他合伙人签订合伙协议，履行出资义务。河南空天产业基金于2025年9月6日成立。截至目前，河南 空天产业基金合伙人已实缴出资2.81亿元。 ...

格隆汇11月24日丨中原内配(002448.SZ)公布，为进一步提升公司资源整合能力，优化资产配置， 中原内配集团股份有限公司拟以0元价格受让焦作通财创新创业投资基金(有限合伙)(简称"焦作通财")持 有的河南空天产业基金合伙企业(有限合伙)(简称"河南空天产业基金"或"合伙企业")对应认缴出资 5,000.00万元(实缴出资额0元)的合伙份额，并作为有限合伙人与河南空天产业基金其他合伙人签订合伙 协议，履行出资义务。 ...

中原内配(002448.SZ)公告，公司拟以0元价格受让焦作通财创新创业投资基金(有限合伙)(简称"焦作通 财")持有的河南空天产业基金合伙企业(有限合伙)(简称"河南空天产业基金")对应认缴出资5000.00万元 (实缴出资额0元)的合伙份额，并作为有限合伙人与河南空天产业基金其他合伙人签订合伙协议，履行 出资义务。 ...

智通财经APP讯，中原内配(002448.SZ)公告，公司拟以0元价格受让焦作通财创新创业投资基金(有限合 伙)(简称"焦作通财")持有的河南空天产业基金合伙企业(有限合伙)(简称"河南空天产业基金")对应认缴 出资5000.00万元(实缴出资额0元)的合伙份额，并作为有限合伙人与河南空天产业基金其他合伙人签订 合伙协议，履行出资义务。 ...